27 results
8-K
EX-10.1
HBIO
Harvard Bioscience Inc.
19 May 21
Departure of Directors or Certain Officers
4:20pm
and market conditions since such sale; (iii) an independent valuation of the Shares (by a qualified valuation expert); or (iv) such other methodologies
8-K
EX-10.1
k78flbza
23 Apr 20
Entry into a Material Definitive Agreement
9:19am
8-K
EX-10.1
gft004
7 Nov 18
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-2.2
5md580d8n2u 105
9 Jan 15
Expected to Add $4 Million to $5 Million in Revenue in 2015
12:00am
8-K
EX-2.1
6088xd1a
9 Jan 15
Expected to Add $4 Million to $5 Million in Revenue in 2015
12:00am
8-K
EX-2.1
zuzp8qsqlnsq
1 Oct 14
Expected to Add $7.5 Million to $8.5 Million in Revenue in 2015
12:00am